Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $151.4800 (1.76%) ($149.1000 - $153.6300) on Wed. Nov. 21, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.91% (three month average) | RSI | 34 | Latest Price | $151.4800(1.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.5% a day on average for past five trading days. | Weekly Trend | LGND declines -4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.455% in a week (0% probabilities). TLT(-16%) VXX(-15%) VIXM(-11%) UUP(-9%) GDXJ(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.455% (StdDev 2.91%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
1 - 5 Day Possible Target | $143.77(-5.09%) | Resistance Level | $159.38 | 5 Day Moving Average | $151.05(0.28%) | 10 Day Moving Average | $153.39(-1.25%) | 20 Day Moving Average | $159.38(-4.96%) | To recent high | -44.8% | To recent low | 2.5% | Market Cap | $2.434b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |